| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $102.5M | +63.5% |
| SG&A Expense | $23.6M | +12.8% |
| Operating Income | -$126.1M | -50.8% |
| Income Tax | $0 | — |
| Net Income | -$117.3M | -43.3% |
| EPS (Basic) | -$3.44 | -22.9% |
| EPS (Diluted) | -$3.44 | -22.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.9M | +58.1% |
| Short-term Investments | $1.1M | +0.0% |
| Current Assets | $179.2M | +52.1% |
| Total Assets | $199.9M | +54.6% |
| Current Liabilities | $22.9M | +19.7% |
| Total Liabilities | $30.7M | +47.8% |
| Stockholders' Equity | $169.2M | +55.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$96.6M | -54.8% |
| Capital Expenditures | $3.4M | +227.2% |
| Investing Cash Flow | -$2.2M | -108.1% |
| Financing Cash Flow | $163.8M | — |
| Free Cash Flow | -$100.0M | -57.6% |